HUBBELL ($HUBB) posted quarterly earnings results on Tuesday, October 28th. The company reported earnings of $5.17 per share, beating estimates of $5.08 by $0.09. The company also reported revenue of $1,502,400,000, missing estimates of $1,564,494,084 by $-62,094,084.
You can see Quiver Quantitative's $HUBB stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
HUBBELL Insider Trading Activity
HUBBELL insiders have traded $HUBB stock on the open market 2 times in the past 6 months. Of those trades, 0 have been purchases and 2 have been sales.
Here’s a breakdown of recent trading of $HUBB stock by insiders over the last 6 months:
- GERBEN BAKKER (Chairman, President & CEO) sold 7,723 shares for an estimated $2,970,497
- CARLOS M CARDOSO sold 400 shares for an estimated $154,516
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
HUBBELL Hedge Fund Activity
We have seen 446 institutional investors add shares of HUBBELL stock to their portfolio, and 374 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- WELLINGTON MANAGEMENT GROUP LLP added 749,806 shares (+565.9%) to their portfolio in Q2 2025, for an estimated $306,228,268
- MARSHALL WACE, LLP removed 613,883 shares (-92.7%) from their portfolio in Q2 2025, for an estimated $250,715,956
- BOSTON PARTNERS added 562,278 shares (+inf%) to their portfolio in Q2 2025, for an estimated $229,639,957
- PRICE T ROWE ASSOCIATES INC /MD/ added 411,070 shares (+35.2%) to their portfolio in Q2 2025, for an estimated $167,885,098
- NORGES BANK removed 404,622 shares (-86.8%) from their portfolio in Q2 2025, for an estimated $165,251,671
- VICTORY CAPITAL MANAGEMENT INC added 375,378 shares (+101.7%) to their portfolio in Q2 2025, for an estimated $153,308,128
- MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. removed 367,054 shares (-100.0%) from their portfolio in Q2 2025, for an estimated $149,908,524
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
HUBBELL Government Contracts
We have seen $88,304 of award payments to $HUBB over the last year.
Here are some of the awards which we have have seen pay out the most over the last year:
To track government contracts to publicy traded companies, check out Quiver Quantitative's government contracts dashboard.
HUBBELL Congressional Stock Trading
Members of Congress have traded $HUBB stock 1 times in the past 6 months. Of those trades, 0 have been purchases and 1 have been sales.
Here’s a breakdown of recent trading of $HUBB stock by members of Congress over the last 6 months:
- REPRESENTATIVE JEFFERSON SHREVE sold up to $50,000 on 05/12.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
HUBBELL Analyst Ratings
Wall Street analysts have issued reports on $HUBB in the last several months. We have seen 3 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Mizuho issued a "Outperform" rating on 10/17/2025
- Stephens & Co. issued a "Overweight" rating on 09/11/2025
- Wells Fargo issued a "Overweight" rating on 09/02/2025
To track analyst ratings and price targets for HUBBELL, check out Quiver Quantitative's $HUBB forecast page.
HUBBELL Price Targets
Multiple analysts have issued price targets for $HUBB recently. We have seen 5 analysts offer price targets for $HUBB in the last 6 months, with a median target of $480.0.
Here are some recent targets:
- Brett Linzey from Mizuho set a target price of $480.0 on 10/17/2025
- Stephen Tusa from JP Morgan set a target price of $458.0 on 10/15/2025
- Tommy Moll from Stephens & Co. set a target price of $500.0 on 09/11/2025
- Joseph O'Dea from Wells Fargo set a target price of $490.0 on 09/02/2025
- Julian Mitchell from Barclays set a target price of $431.0 on 08/01/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.